Lilly Opens Labs, Scientists Pretend To R&D Like Experts
In sunny San Diego, Eli Lilly & Co. puffed out their biotech chest by launching the Gateway Labs incubator, a shiny new playground for science geeks to pretend they understand R&D results. Chief Science Officer Daniel Skovronsky, who sounds like he moonlights as a superhero, held court with broad statements that sound impressively vague about the company’s R&D roadmap. No exact dollar figures, no timelines—just biotech bravado with a coastal breeze. If you were expecting actual breakthroughs, tough luck: it’s more of a 'build it and we hope drugs happen' vibe. Welcome to science startups, where buzzwords flow freer than lab coffee.
Share the Story
Nothing says breakthrough biotech like an official opening where the top scientist talks about broad R&D plans in San Diego and the real science is guessing what those plans actually are. Spoiler: we’re all terrible drivers of our own life projects.
Daniel Skovronsky officially announced the biotech incubator and a vague plan to do more biotech things. San Diego’s science scene now has a shiny sign and no actual new drugs, yet.
Welcome to Eli Lilly’s Gateway Labs: where science gets a beachfront address, a nebulous R&D pitch, and all the optimism of your 'new year, new me' resolutions.
Source: Statnews | Published: 9/30/2025 | Author: Jonathan Wosen
More Articles in Science
America Celebrates Lower Gun Deaths While Puffing More Vape Clouds
Grandfather Gifts $1,500 with Guest Star Role for Financial Advisor
TCL and Hisense Finally Throw Shade at Sony, LG, Samsung’s Premium TV Party
SpaceX’s Starlink Satellite Has Midlife Crisis, Explodes Dramatically
Scientists Officially Declare Adulthood Brain Is Just Long Teenage Brain Saga
Ozone Hole Slowly Shrinks, Planet Pretends To Care Until Next Summer
Leonids Showers: Stargaze Naps & Smoke Trails, Not Meteorites
Bezos' New Glenn: Rocket Spat Out Mars, Slurped Booster Back
